HomeMy WebLinkAbout08.02.24 Board Correspondence - Aaron Siri on Vaccine Manufacturers Financial M.ATTENTION: This message originated from outside Butte County. Please exercise judgment before opening
attachments, clicking on links, or replying..
From:lance dreiss
To:Senator.Dahle@senate.ca.gov; Assemblymember.Gallagher@assembly.ca.gov; District Attorney;
davidhollister@countyofplumas.com; pcbs@countyofplumas.com; Durfee, Peter; sheriff@pcso.net; Kimmelshue,
Tod; Pickett, Andy; Connelly, Bill; Ring, Brian; JULIE THREET; Waugh, Melanie; Ritter, Tami; Teeter, Doug; Clerk
of the Board; Congressman Doug LaMalfa; Stephens, Brad J.
Subject:Aaron Siri on Vaccine Manufacturers Financial Motivation Over Vaccine Safety.
Date:Friday, August 2, 2024 9:57:09 AM
Public Record
“I think the primary driver is that when it comes to drug products, the manufacturers
are on the hook after it's licensed in terms of liability. So if they license a product, a
drug that causes widespread harm, they've got to pay for those injuries, that
economic interest drives them to want to know the safety of those products before
they go on the market, because they could stand to lose far more money than they
make. But when it comes to vaccine products, because the National Childhood Injury
Act of 1986, they're not on the hook. Vaccine manufacturers, pharmaceutical
companies know that they are not gonna have to pay for virtually any injuries caused
by their vaccine products. And so they don't have the same economic incentive when
they do those clinical trials for vaccines to ensure their safety before they go on the
market.”
Aaron Siri - 07/30/2024
https://rumble.com/v594i7h-aaron-siri-on-vaccine-manufacturers-financial-motivation-over-
vaccine-safet.html
diana dreiss